Dichotomous location of 160 atypical femoral fractures

Background and purpose The risk of atypical fracture of the femur is associated with bisphosphonate use. While characterizing atypical fractures from a previous nationwide study in radiographic detail, we had the impression that the fractures were located either in the subtrochanteric region or in the shaft. We determined whether there is a dichotomy in this respect. Patients and methods The distance between the atypical fractures and the lesser trochanter was measured on plain radiographs from 129 of 160 patients with atypical fractures, taken from 2008 through 2010. Analysis of the distances measured showed 2 clusters, which were then analyzed with regard to bisphosphonate use and age. Results The distribution of the distances would be best described as 2 clusters, with a dichotomy at 8 cm. The proximal (subtrochanteric) cluster comprised 25 patients who were generally younger (median 71 years) than the 104 patients in the cluster with shaft fractures (median 80 years). The 95% CI for the difference between medians was 4–11 years. Of the patients with subtrochanteric fractures, 18 of 25 used bisphosphonates as compared to 89 of 104 with shaft fractures. Interpretation The younger age and possibly smaller proportion of bisphosphonate users in the subtrochanteric cluster may be compatible with a greater influence of mechanical stress in the underlying pathophysiology of proximal fractures.

[1]  J. Schilcher,et al.  Atypical fractures do not have a thicker cortex , 2012, Osteoporosis International.

[2]  R. Stern,et al.  Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta—a case report , 2012, Acta orthopaedica.

[3]  A. Boskey,et al.  Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality , 2012, Arthritis Research & Therapy.

[4]  A. Rydholm Highly different risk estimates for atypical femoral fracture with use of bisphosphonates – debate must be allowed! , 2012, Acta orthopaedica.

[5]  A. Reigstad,et al.  Atypical fracture of the ulna associated with alendronate use , 2011, Acta orthopaedica.

[6]  S. Ott,et al.  Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures , 2011, Osteoporosis International.

[7]  T. Brown,et al.  Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294)) , 2011 .

[8]  M. Tan,et al.  Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures — a case report , 2011, Acta orthopaedica.

[9]  T. Howe,et al.  Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology. , 2011, Singapore medical journal.

[10]  Klaus Klaushofer,et al.  Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  I. McNamara,et al.  Classification of subtrochanteric femoral fractures. , 2010, Injury.

[12]  S. Cummings,et al.  Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density , 2010 .

[13]  S. Cummings,et al.  Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. , 2009, The Journal of clinical endocrinology and metabolism.

[14]  A. Phillips The femur as a musculo-skeletal construct: a free boundary condition modelling approach. , 2009, Medical engineering & physics.

[15]  S. Cummings,et al.  Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. , 2006, JAMA.

[16]  J. O'Connor,et al.  Strain distribution within the human femur due to physiological and simplified loading: Finite element analysis using the muscle standardized femur model , 2003, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[17]  Adrian E. Raftery,et al.  Model-Based Clustering, Discriminant Analysis, and Density Estimation , 2002 .

[18]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[19]  Robert W. Bucholz,et al.  The Comprehensive Classification of Fractures of Long Bones. , 1991 .

[20]  John C. Koch,et al.  The laws of bone architecture , 1917 .

[21]  J. Ranstam,et al.  Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. , 2013, Bone.

[22]  M. Swiontkowski,et al.  Bisphosphonate Use and Atypical Fractures of the Femoral Shaft , 2012 .

[23]  Adrian E. Raftery,et al.  mclust Version 4 for R : Normal Mixture Modeling for Model-Based Clustering , Classification , and Density Estimation , 2012 .

[24]  J. Dungan Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur , 2011 .

[25]  W. Taylor,et al.  Physiologically based boundary conditions in finite element modelling. , 2007, Journal of biomechanics.